Antigenic Change in Human Influenza A(H2N2) Viruses Detected by Using Human Plasma from Aged and Younger Adult Individuals.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
23 10 2019
Historique:
received: 30 09 2019
revised: 21 10 2019
accepted: 21 10 2019
entrez: 27 10 2019
pubmed: 28 10 2019
medline: 2 10 2020
Statut: epublish

Résumé

Human influenza A(H2N2) viruses emerged in 1957 and were replaced by A(H3N2) viruses in 1968. The antigenicity of human H2N2 viruses has been tested by using ferret antisera or mouse and human monoclonal antibodies. Here, we examined the antigenicity of human H2N2 viruses by using human plasma samples obtained from 50 aged individuals who were born between 1928 and 1933 and from 33 younger adult individuals who were born after 1962. The aged individuals possessed higher neutralization titers against H2N2 viruses isolated in 1957 and 1963 than those against H2N2 viruses isolated in 1968, whereas the younger adults who were born between 1962 and 1968 possessed higher neutralization titers against H2N2 viruses isolated in 1963 than those against other H2N2 viruses. Antigenic cartography revealed the antigenic changes that occurred in human H2N2 viruses during circulation in humans for 11 years, as detected by ferret antisera. These results show that even though aged individuals were likely exposed to more recent H2N2 viruses that are antigenically distinct from the earlier H2N2 viruses, they did not possess high neutralizing antibody titers to the more recent viruses, suggesting immunological imprinting of these individuals with the first H2N2 viruses they encountered and that this immunological imprinting lasts for over 50 years.

Identifiants

pubmed: 31652870
pii: v11110978
doi: 10.3390/v11110978
pmc: PMC6893718
pii:
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201400008C
Pays : United States

Déclaration de conflit d'intérêts

Y.K. has received speaker’s honoraria from Toyama Chemical and Astellas Inc.; has received grant support from Chugai Pharmaceuticals, Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Otsuka Pharmaceutical Co., Ltd., and Denka Seiken Co., Ltd.; and is a co-founder of FluGen. Y.Arai. has received a research grant from Daiichi Sankyo Co, Ltd. and Novartis Pharma K K. The other authors have no conflicts of interest.

Références

Nature. 2011 Mar 10;471(7337):157-8
pubmed: 21390107
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
J Virol. 2015 Apr;89(7):3763-75
pubmed: 25609810
J Infect Dis. 2016 Jan 1;213(1):31-8
pubmed: 26142433
Nature. 2009 Jun 18;459(7249):931-9
pubmed: 19525932
Science. 2004 Jul 16;305(5682):371-6
pubmed: 15218094
J Clin Virol. 2018 Nov;108:105-111
pubmed: 30292135
J Virol. 2019 Apr 3;93(8):
pubmed: 30700609
Arch Virol. 1984;81(3-4):239-50
pubmed: 6477129
J Virol. 2012 Jun;86(11):6334-40
pubmed: 22457520
Cell Host Microbe. 2018 Oct 10;24(4):569-578.e4
pubmed: 30308159
EBioMedicine. 2017 Mar;17:182-191
pubmed: 28286060
J Virol. 2015 Feb;89(4):2442-7
pubmed: 25505070
J Virol. 2010 Aug;84(15):7695-702
pubmed: 20504935
Virology. 1984 Oct 30;138(2):276-86
pubmed: 6208682
J Infect Dis. 2018 Aug 24;218(7):1054-1060
pubmed: 29762672
J Gen Virol. 2001 Oct;82(Pt 10):2475-84
pubmed: 11562540
Comput Appl Biosci. 1992 Jun;8(3):275-82
pubmed: 1633570

Auteurs

Yukimasa Matsuzawa (Y)

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. ymatsuza@ims.u-tokyo.ac.jp.

Kiyoko Iwatsuki-Horimoto (K)

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. kenken@ims.u-tokyo.ac.jp.

Yoshinori Nishimoto (Y)

Center for Supercentenarian Medical Research, Shinjuku-ku, Tokyo 160-8582, Japan. ynishimo@z3.keio.jp.

Yukiko Abe (Y)

Center for Supercentenarian Medical Research, Shinjuku-ku, Tokyo 160-8582, Japan. yukiko_abe@keio.jp.

Satoshi Fukuyama (S)

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. fukuyamarry@gmail.com.

Taiki Hamabata (T)

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. hamabata@ims.u-tokyo.ac.jp.

Moe Okuda (M)

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. kk176356@stu-cbms.k.u-tokyo.ac.jp.

Yui Go (Y)

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. yuigo555@gmail.com.

Tokiko Watanabe (T)

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. tokiko.watanabe@wisc.edu.

Masaki Imai (M)

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. mimai@ims.u-tokyo.ac.jp.

Yasumichi Arai (Y)

Center for Supercentenarian Medical Research, Shinjuku-ku, Tokyo 160-8582, Japan. yasumich@keio.jp.

Ron A M Fouchier (RAM)

Department of Viroscience, Erasmus Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. r.fouchier@erasmusmc.nl.

Seiya Yamayoshi (S)

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. yamayo@ims.u-tokyo.ac.jp.

Yoshihiro Kawaoka (Y)

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. yoshihiro.kawaoka@wisc.edu.
Department of Special Pathogens, International Research Center for Infectious Diseases, Institute Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. yoshihiro.kawaoka@wisc.edu.
Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA. yoshihiro.kawaoka@wisc.edu.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH